跳至主要内容
临床试验/NCT00532519
NCT00532519Unknown不适用

Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis

Hadassah Medical Organization1 个研究点 分布在 1 个国家开始时间: 2007年9月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
试验地点
1

研究概览

简要总结

Prurigo nodularis (PN) is a common dermatological disorder, manifested as scaly nodules which appear mainly on the extensor surfaces of the limbs. PN may appear secondarily to skin scratching in chronic hepatitis, liver cirrhosis, uremia, hypothyroidism etc. Nevertheless, in many cases no underlying physical disease is present. According to the literature, in fifty percent of the patients there is co-morbidity with depression, anxiety or somatoform disorders.

We hypothesize that a group of these patients may benefit from antidepressant therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • prurigo nodularis
  • age: 18-70 years
  • agreed to participate

排除标准

  • younger than 18 or older than 70
  • pregnant or lactating women
  • chronic diseases: cancer, neurological disorders, diseases that are known to be associated with pruritus such as liver cirrhosis, uremia, etc.
  • sensitivity to cipralotam
  • psychosis, bi-polar disorder, substance addiction, use of antidepressant in the previous year
  • use of systemic therapies to prurigo nodularis such as thalidomide, cyclosporine

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
不适用
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical RoutinePrurigo Nodularis
NCT06087627Sanofi110
尚未招募
3 期
A Randomized, Double-blinded, Self-controlled Clinical Study of Intralesional Injection of 5-fluorouracil Plus Triamcinolone for the Treatment of Refractory Nodular PrurigoNodular Prurigo
NCT06524323Second Affiliated Hospital, School of Medicine, Zhejiang University60
进行中(未招募)
1 期
Efficacy of ruxolitinib cream in Prurigo nodularis patients: A randomized, placebo-controlled pilot study (PRUX)Patients with symptomatic Prurigo nodularis with active skin manifestationsMedDRA version: 20.0Level: LLTClassification code 10037084Term: Prurigo nodularisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 20.0Level: PTClassification code 10037083Term: PrurigoSystem Organ Class: 10040785 - Skin and subcutaneous tissue disorders
EUCTR2019-004739-22-DERheinische Friedrich-Wilhelms-Universität Bonn20
已完成
不适用
Clinicopathological Characteristics and Etiologies of Erythema Nodosum: A 10-year Retrospective StudyErythema NodosumErythema NodosumSeptal panniculitisSeptal panniculitis
TCTR20190816001Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital169
尚未招募
不适用
Follow-up of patients with chronic nodular prurigoL28.1L28.2Other prurigoPrurigo nodularis
DRKS00022555Department of Dermatology and Center for Chronic Pruritus100